HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Markus G Manz Selected Research
Markus G Manz Research Topics
Disease
25
Neoplasms (Cancer)
04/2024 - 03/2002
19
Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
02/2024 - 03/2014
9
Infections
01/2024 - 10/2006
9
Leukemia
01/2022 - 03/2014
7
Lymphoma (Lymphomas)
01/2023 - 03/2002
6
Hematologic Neoplasms (Hematological Malignancy)
11/2023 - 01/2010
4
COVID-19
02/2024 - 01/2022
4
Graft vs Host Disease (Graft-Versus-Host Disease)
10/2022 - 05/2004
4
Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
10/2019 - 01/2017
3
Hematologic Diseases (Blood Diseases)
01/2022 - 09/2012
3
Inflammation (Inflammations)
12/2021 - 03/2010
3
Residual Neoplasm
01/2021 - 11/2017
3
Primary Myelofibrosis (Myelosclerosis)
01/2020 - 01/2016
3
Bacterial Infections (Bacterial Infection)
01/2019 - 08/2014
3
Multiple Myeloma
01/2019 - 01/2018
2
Langerhans-Cell Histiocytosis (Histiocytosis, Langerhans Cell)
12/2023 - 01/2021
2
Hairy Cell Leukemia
02/2023 - 05/2017
2
Communicable Diseases (Infectious Diseases)
01/2023 - 02/2011
2
Bone Marrow Failure Disorders
10/2022 - 10/2016
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
05/2022 - 01/2018
2
Viremia
01/2022 - 10/2006
2
Brain Diseases (Brain Disorder)
06/2021 - 01/2018
2
Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
01/2021 - 02/2018
2
Thrombocytosis (Thrombocythemia)
10/2020 - 10/2014
2
Sickle Cell Anemia (Hemoglobin S Disease)
08/2020 - 07/2020
2
Essential Thrombocythemia
01/2020 - 01/2016
2
Virus Diseases (Viral Diseases)
01/2020 - 01/2016
2
Polycythemia (Erythrocytosis)
01/2020 - 10/2014
2
Opportunistic Infections (Opportunistic Infection)
10/2018 - 01/2010
2
Body Weight (Weight, Body)
01/2018 - 01/2016
2
Pain (Aches)
01/2018 - 09/2012
1
Colorectal Neoplasms (Colorectal Cancer)
04/2024
1
Colonic Neoplasms (Colon Cancer)
04/2024
1
Amyloidosis
02/2024
1
Transthyretin-Related Hereditary Amyloidosis
02/2024
1
Glioma (Gliomas)
11/2023
1
Glioblastoma (Glioblastoma Multiforme)
11/2023
1
Cytokine Release Syndrome
01/2023
1
Non-Hodgkin Lymphoma (Lymphosarcoma)
01/2023
1
Prostatic Neoplasms (Prostate Cancer)
01/2023
1
Neurogenic Diabetes Insipidus (Central Diabetes Insipidus)
01/2023
1
cell-associated neurotoxicity
01/2023
1
Severe Acute Respiratory Syndrome
01/2023
1
B-Cell Lymphoma (Lymphoma, B Cell)
01/2022
1
Acute Kidney Injury (Acute Renal Failure)
01/2022
Drug/Important Bio-Agent (IBA)
8
Antigens
IBA
04/2024 - 03/2014
8
Proteins (Proteins, Gene)
FDA Link
11/2023 - 10/2009
7
Cytokines
IBA
03/2024 - 03/2010
7
Chimeric Antigen Receptors
IBA
11/2023 - 01/2020
5
Vaccines
IBA
02/2024 - 10/2010
5
Antibodies
IBA
01/2024 - 03/2014
4
Cytarabine (Cytosar-U)
FDA Link
Generic
02/2018 - 12/2015
3
Bispecific Antibodies
IBA
04/2024 - 06/2021
3
Rituximab (Mabthera)
FDA Link
01/2023 - 01/2016
3
DNA (Deoxyribonucleic Acid)
IBA
01/2022 - 01/2013
3
Interleukin-6 (Interleukin 6)
IBA
12/2021 - 01/2016
3
Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)
IBA
01/2020 - 02/2011
2
Monoclonal Antibodies
IBA
02/2024 - 01/2019
2
Mitogen-Activated Protein Kinases
IBA
12/2023 - 01/2021
2
Biomarkers (Surrogate Marker)
IBA
01/2022 - 01/2018
2
Clofarabine (Clolar)
FDA Link
01/2022 - 03/2017
2
Neutralizing Antibodies
IBA
01/2022 - 01/2014
2
Ligands
IBA
11/2021 - 01/2020
2
Fluorescein (Funduscein)
FDA Link
Generic
11/2021 - 01/2020
2
Lenalidomide (CC 5013)
FDA Link
05/2021 - 01/2021
2
Interferons
IBA
10/2020 - 05/2017
2
Memantine (Namenda)
FDA Link
08/2020 - 07/2020
2
Interleukin-3 (Interleukin 3)
IBA
01/2020 - 02/2011
2
Immunoglobulin Fragments
IBA
01/2020 - 01/2019
2
RNA (Ribonucleic Acid)
IBA
12/2019 - 10/2006
2
Sphingosine-1-Phosphate Receptors
IBA
10/2019 - 01/2018
2
Anti-Bacterial Agents (Antibiotics)
IBA
01/2019 - 11/2014
2
Granulocyte Colony-Stimulating Factor (G-CSF)
IBA
01/2016 - 08/2014
2
Membrane Proteins (Integral Membrane Proteins)
IBA
03/2014 - 03/2002
2
posaconazole
FDA Link
01/2014 - 09/2012
1
Single-Chain Antibodies
IBA
04/2024
1
Carcinoembryonic Antigen
IBA
04/2024
1
Interleukin-12 (IL 12)
IBA
03/2024
1
AA amyloidosis
IBA
02/2024
1
tixagevimab
IBA
02/2024
1
cilgavimab
IBA
02/2024
1
Cyclophosphamide (Cytoxan)
FDA Link
Generic
10/2023
1
Vemurafenib
IBA
02/2023
1
purine
IBA
02/2023
1
TGN-1412 (TGN1412)
IBA
01/2023
1
tisagenlecleucel
IBA
01/2023
1
T-Cell Antigen Receptors (T-Cell Receptor)
IBA
01/2023
1
Omega-3 Fatty Acids (Omega 3 Fatty Acids)
IBA
01/2022
1
Vitamin D
FDA Link
Generic
01/2022
1
Creatinine
IBA
01/2022
1
Cholecalciferol (Vitamin D3)
FDA Link
01/2022
Therapy/Procedure
16
Therapeutics
03/2024 - 04/2009
13
Drug Therapy (Chemotherapy)
02/2024 - 12/2015
7
Immunotherapy
12/2023 - 01/2021
5
Cell Transplantation
02/2024 - 10/2018
5
Hematopoietic Stem Cell Transplantation
09/2023 - 01/2010
5
Transplantation
01/2023 - 05/2004
4
Stem Cell Transplantation
05/2022 - 11/2017
2
Homologous Transplantation
10/2023 - 01/2017
1
Castration
01/2023